Gansu Chengji biopharmaceutical Co., Ltd., a wholly-owned subsidiary of Shenzhen Hanyu Pharmaceutical Co., Ltd., is a large-scale high-tech modern comprehensive enterprise integrating R & D, production and sales of drugs and medical devices. It is a dual license enterprise with "drug production license" and "medical device production license". The company covers an area of 117 mu, the plant greening rate is 48.68%, the registered capital is 229 million yuan, and has 67 patent technologies. The company has passed the new GMP certification of small volume injection, freeze-dried powder injection and solid preparation. The company has 171 national drug approval numbers and 9 medical device registration certificates. The company has 10 production lines, such as the production line of small volume injection, the production line of lyophilized powder injection, the production line of solid preparation tablets, capsules, granules, powders and sterile medical devices. The company is mainly engaged in the R & D, production and sales of anti-tumor drugs, cardiovascular and cerebrovascular diseases, antibiotics, diabetes and other chronic diseases, as well as automatic injection, automatic dissolution of medical equipment products.